Qingdao Baheal Medical Inc
SZSE:301015
Qingdao Baheal Medical Inc
Cash from Operating Activities
Qingdao Baheal Medical Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Cash from Operating Activities
¥609.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Operating Activities
¥17.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
36%
|
CAGR 10-Years
13%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Operating Activities
¥2.4B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
14%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Operating Activities
¥4.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Operating Activities
¥2.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
84%
|
CAGR 10-Years
27%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Operating Activities
¥3.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
25%
|
See Also
What is Qingdao Baheal Medical Inc's Cash from Operating Activities?
Cash from Operating Activities
609.7m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Cash from Operating Activities amounts to 609.7m CNY.
What is Qingdao Baheal Medical Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
63%
Over the last year, the Cash from Operating Activities growth was 99%.